DCM
BCYC

Driehaus Capital Management’s Bicycle Therapeutics BCYC Stock Holding History

Driehaus Capital Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-229,290
Closed -$10.1M – 365
2022
Q1 		$10.1M Sell
229,290
-37,742
-14% -$1.76M 0.12% 229
2021
Q4 		$16.3M Buy
+267,032
New +$14.7M 0.17% 179

Other funds holding BCYC

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Driehaus Capital Management's BCYC Position: Q2 2022 in Review

Driehaus Capital Management sold out of Bicycle Therapeutics (BCYC) in Q2 2022, closing a stake of 229,290 shares — an estimated $10.1M sold.

Driehaus Capital Management first reported a position in BCYC in Q4 2021 and held it in 2 quarters. The position peaked at $16.3M in Q4 2021. 81 funds tracked by Wall St. Rank hold BCYC as of Q2 2022.

  • Driehaus Capital Management reported no remaining Bicycle Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Driehaus Capital Management sold 229,290 Bicycle Therapeutics shares in Q2 2022, an estimated $10.1M.
  • Driehaus Capital Management first reported a position in Bicycle Therapeutics in Q4 2021 and held it in 2 quarters.
  • Driehaus Capital Management's Bicycle Therapeutics position peaked at $16.3M in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2022.

Based on Driehaus Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.